Table 2 The association between ANXA2 expression with clinical pathologic characteristics in 42 NB patients
ANXA2 expression | |||||
|---|---|---|---|---|---|
Total | Low (n = 24) | High (n = 18) | P value | ||
Gender | 1.000 | ||||
Male | 23 | 13 | 10 | ||
Female | 19 | 11 | 8 | ||
Age at diagnosis | 0.065 | ||||
<18 months | 23 | 10 | 13 | ||
>18 months | 19 | 14 | 5 | ||
Primary site | 0.109 | ||||
Retroperitoneum | 34 | 17 | 17 | ||
Postmediastinum | 8 | 7 | 1 | ||
Stage | 0.010 | ||||
I-II | 20 | 16 | 4 | ||
III-IV | 20 | 7 | 13 | ||
IVs | 2 | 1 | 1 | ||
Lymphatic metastasis | 0.012 | ||||
Positive | 18 | 6 | 12 | ||
Negative | 24 | 18 | 6 | ||
Histology | 0.523 | ||||
undifferentiated/poorly differentiated | 22 | 14 | 8 | ||
well-differentiated | 18 | 9 | 9 | ||
NA | 2 | 1 | 1 | ||
Bone marrow metastasis | 0.000 | ||||
Positive | 9 | 0 | 9 | ||
Negative | 33 | 24 | 9 | ||